欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/V/0413/006
药品名称Moxiclear 400 mg + 100 mg spot-on solution for very-large dogs
活性成分
    • imidacloprid 10.0 % (W/V)
    • MOXIDECTIN 2.5 % (W/V)
剂型Spot-on solution
上市许可持有人Norbrook Laboratories Limited Station Works NEWRY BT35 6JP Co Down Northern Ireland
参考成员国 - 产品名称Ireland (IE)
Moxiclear 400 mg + 100 mg spot-on solution for very large dogs
互认成员国 - 产品名称
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Hungary (HU)
    • Bulgaria (BG)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
许可日期2018/03/28
最近更新日期2025/02/14
药物ATC编码
    • QP54AB52 moxidectin, combinations
申请类型
  • TypeLevel1：non-food
  • TypeLevel2：Pharmaceutical
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase